On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
MondayDec 06, 2021 11:35 am

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) CEO Reiterates Commitment to Simplifying Lightning Network Access and Use

Since January, The Lightning Network has seen a growth rate of over 205%, according to company co-founder and CEO Shone Anstey Mid-November, LQwD took part in the Adopting Bitcoin – A Lightning Summit in El Salvador, a conference that brought together renowned industry experts in the Bitcoin and Lightning Network Community to discuss the future of money and payments in Central America and abroad LQwD announced that it spent a total of C$9.2 million (US$7.17 million) to purchase 150 Bitcoins, with an average cost of approximately C$61,000 (US$48,000) per Bitcoin. This purchase further strengthens the company’s strategic growth initiative The…

Continue Reading

MondayDec 06, 2021 10:44 am

FDA green lights Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Psychedelic Drug Trial for Treating Fibromyalgia, After Completing IND Process

Pharmaceutical company Tryp Therapeutics is advancing research into the ability to treat unmet medical needs by using synthetic psychedelic drug candidates generally regarded as illegal and of no practical value under federal drug standards The company is demonstrating its faith in the potential of psychedelic medicine by advancing its proprietary TRP-8802 psilocybin candidate toward Phase 2a drug trials through the FDA’s Investigational New Drug process The FDA has notified the company that its review of the IND for using TRP-8802 to treat fibromyalgia is complete and a trial planned in conjunction with the University of Michigan may proceed to patient…

Continue Reading

MondayDec 06, 2021 9:30 am

American Cannabis Partners Cater to Increasingly Discerning Customer Base Through Cultivation of Premium, Proprietary Cannabis Strains

The cannabis industry in California and the United States is undergoing a metamorphosis, reflecting scores of new marijuana markets and business opportunities for cultivators, manufacturers and retailers within the sector American Cannabis Partners, a multi-state, vertically integrated operator with cultivation operations across the states of Michigan and California has sought to differentiate itself through its high-quality end product The company, which boasts a strong personal and positive relationship with Jamaica and its people, has aligned its production processes with traditional Jamaican cultivation techniques, resulting in greater production yields, higher THC levels and more pronounced terpenes ACP recently revealed that it…

Continue Reading

MondayDec 06, 2021 9:00 am

Tingo, Inc. (IWBB) Poised to Tackle Social and Economic Challenges in Africa Through Agriculture Innovation as the Sector Is Expected to Reach $ 1 Trillion

Agriculture has massive social and economic impact in Africa: it generates up to 40% of GDP, provides livelihood for 70% of the continent's population; expected to reach $1 trillion in value by 2030 Still, the sector suffers from considerable inefficiencies hindering growth: low productivity, fragmented supply chains, and excessive post-harvest losses Tingo aims to solve these challenges for Africa's key industry: NWASSA platform streamlines agribusiness supply chains by connecting actors in one digital marketplace, intends to provide direct connection to company's SuperApp that offers mobile wallet Tingo (OTCQB: IWBB), a digital service agri-fintech technology company focused on providing financial services…

Continue Reading

MondayDec 06, 2021 9:00 am

Sharing Services Global Corp.’s (SHRG) Happy Co. Operating in Resilient, Post-Pandemic Sector

In 2020, direct sales saw record highs in sales, sellers and customers in the U.S. Growth across many categories within direct selling reflects broader consumer trends The Happy Co. is one of fastest-growing companies in the social-marketing, direct-selling industries The resiliency of the direct-selling industry has never been more evident than during the global pandemic. Looking forward, the country’s economic situation remains fragile, but direct sales remains a bright spot on the horizon. A recent Direct Selling News article, titled “Four Reasons for Direct-Selling Optimism Post-Pandemic,” touts all that is right with the space (https://ibn.fm/sbexN) — a space in which…

Continue Reading

MondayDec 06, 2021 9:00 am

SRAX Inc. (NASDAQ: SRAX) Reports Record Third Quarter; Raises Fourth Quarter Top-Line Guidance

SRAX reported their 3Q21 quarterly results on November 15, 2021 The company reported 3Q21 revenues of $8.3 million, +219% YoY and +8% QoQ SRAX also reported that their 3Q21 EBITDA net loss narrowed to -$790k, with the company simultaneously revealing that their gross margin had widened to 78% SRAX’s investor intelligence platform, Sequire announced that their subscribers had swelled to 250 companies as of 3Q21, up from 225 companies at the end of the second quarter SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, recently published its…

Continue Reading

FridayDec 03, 2021 12:28 pm

Q1 Diagnostic Coverage & Reimbursement Conference, Boston

Date: December 6-7, 2021 Venue: Boston, MA Reimbursement executives attempt to comply with stringent commercial and public payer standards as the diagnostic industry evolves and expands into ever more specialized areas of testing. Provisions and specific evidence required to ensure coverage are always evolving, but the technology appears to be progressing even faster, posing unique hurdles in showing product value and integrating innovative diagnostics into existing payment schemes. The Diagnostic Coverage & Reimbursement conference has brought together more than 1200 industry professionals over the last ten years to discuss crucial challenges affecting diagnostic technology pricing, allowing the industry to better…

Continue Reading

FridayDec 03, 2021 9:30 am

Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Announces Research and Technology Progress, Offers Corporate Update

Investment banking firm The Maxim Group reiterates ‘buy’ rating on MCURF following the company’s updates on pivotal research and technology, including The Desire Project, manufacturing of synthetic ibogaine, and the iSTRYM platform MINDCURE is focused on developing psychedelic compounds to scale science-backed and evidentiary-based mental health therapy worldwide In July, MINDCURE filed for patents on two routes of full chemical synthesis, which initiated the production of Good Laboratory Practice (“GLP”) ibogaine, which will lead to the production of Good Manufacturing Practice (“GMP”) ibogaine to scale and manufacture a global supply of its synthetic ibogaine In addition to this pre-clinical trial,…

Continue Reading

FridayDec 03, 2021 9:30 am

NCIA’s 7th Annual Cannabis Business Summit & Expo Launches BLOOM: A Brands Experience

The NCIA will host the 7th Annual Cannabis Business Summit & Expo on December 15-17, 2021, in San Francisco This year’s event will feature BLOOM: A Brands Experience, designed to provide attendees with the ability to see, touch, and smell a variety of cannabis products on the expo floor In addition to Bloom, the conference will also feature two unique offsite tours, including a visit to the Dark Heart Nursery, as well as a unique cannabis-infused San Francisco city cruise NCIA’s 7th Annual Cannabis Business Summit & Expo takes place at San Francisco’s Moscone Center from December 15-17, 2021. Hosted…

Continue Reading

FridayDec 03, 2021 9:30 am

FingerMotion Inc. (FNGR) Reports on November 22 Annual Meeting Results

FingerMotion released results from the annual meeting held on November 22, 2021 It announced the re-appointment of executive officers and its Board of Directors It also reported on the appointment of an independent accounting firm FingerMotion (OTCQX: FNGR) held its annual meeting of stockholders on November 22, 2021. Among the issues covered included the election of specific figures into the company’s Board of Directors, coupled with the approval of the FNGR 2021 stock incentive plan and executive compensation. The company just announced that various matters were duly ratified and have since been implemented by its Board. They included: The election…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered